Abstract:Objective To investigate the effects of parecoxib sodium preemptive analgesia on perioperative cytokine responses and stress respses and postoperative analgesia in patients undergoing ophthalmology surgery. Methods One hundred ASA Ⅰ- Ⅱ patients undergoing ophthalmology surgery were randomly divided into 2 groups of fifty: the parecoxib group received parecoxib 40 mg by muscle injection, the control group received an equal volume of 0. 9% normal saline two ml. Venous blood samples were obtained at 10 minutes before parecoxib or 0. 9% normal saline was injected (T1) , 30 minutes ( T2) and 60 minutes (T3) after surgery was initiated, the moment when surgery was finished ( T4), 6 hours (T5 ), 12 hours(T6)and 24 hours (T7 ) after surgery was finished for determination of the plasma levels of IL-6, IL-8,IL-1RA,TNF and IL-1β. At the same time, the plasma levels of epinephrine, norepinephrine, cortisol and adrenocorticotropic hormone at Tl - T6 were measured. VAS scores with patients were recorded at 1,2, 6,12,24 h after surgery. Result The change of the plasma levels of IL-6, IL-8, IL-1RA, TNF, IL-1β in the two groups:in the parecoxib group the plasma levels of TNF and IL-1β did not decreased significantly as compared with the control group ( P > 0. 05 ) . The plasma levels of IL-6, IL-8 at T4 - T6 decreased significantly as compared with the control group (P < 0. 01) . The plasma levels of IL-1RA at T3 - T6 decreased significantly as compared with the control group ( P < 0. 01 ). The change of the plasma levels of epinephrine, norepinephrine, cortisol and adrenocorticotropic hormone in the two groups: in the parecoxib group the plasma levels of epinephrine, norepinephrine at T2 ,T3 decreased significantly as compared with the control group ( P < 0. 01 ). In the parecoxib group the plasma levels of cortisol at T2 - T4 decreased significantly as compared with the control group(P <0.01 ). In the parecoxib group the plasma levels of adrenocorticotropie hormone at T2 - T5 decreased significantly as compared with the control group ( P <0. 01 ). Postoperation VAS scores:VAS scores of the parecoxib group were less than that of the control group (P < 0. 05). Conclusion Preoperatively-administered pareeoxib during ophthalmology surgery can produce better analgesia effect, reduce the production of cytokines, decrease central nervous system sensitization so as to improve the quality of postoperative pain relief. At the same time, it can reduce perioperative stress hormone release so as to have a positive effect on post operative recovery.

Clinical assessment of Pranoprofen eyedrops on postoperative inflammation of cataract extraction and non-infection inflammation of the anterior segments of the eye

Effects of parecoxib sodium preemptive analgesia on perioperative cytokine responses and stress responses in patients undergoing ophthalmology surgery

Clinical Assessment of Proanoprefen Eyedrops on Postoperative Inflammation from LASEK

Effects of Pranoprofen on Aqueous Humor Monocyte Chemoattractant Protein-1 Level and Pain Relief During Second-Eye Cataract Surgery

Clinical efficacy of 0.1% pranoprofen in treatment of dry eye patients: a multicenter, randomized, controlled clinical trial.

The necessity of pretreatment with 0.1% pranoprofen for femtosecond-assisted cataract surgery: A single-center, randomized controlled trial

The efficacy of tobramycin dexamethasone combined with pranoprofen in middle-aged and elderly post-cataract patients and the value of improving inflammatory factor levels

Effect of co-administration of pranoprofen/emedastine difumarate eye drops on efficacy, inflammatory factors, tear film stability and immune function in children with allergic conjunctivitis

Effect of a Topical Nonsteroidal Anti-Inflammatory Drug (0.1% Pranoprofen) on VEGF and COX-2 Expression in Primary Pterygium

Design and Evaluation of a Dual-Sensitive In Situ Gel for the Controlled Release of Pranoprofen

Clinical Assessment of Compound Diclofenac Sodium Eyedrops on Postoperative Inflammation of Phacoemulsification and Trabeculectomy

Efficacy and safety of intravenous injection of lidocaine in the treatment of acute primary angle-closure glaucoma: a pilot study

Clinical Efficacy and Safety of Compound Gentamicin Diclofenac Sodium Eyedrops on Postoperative Inflammation of Phacoemulsification and Trabeculectomy

Clinical assessment of 0.1% Diclofenac Sodium eye drops on the treatment of acute allergic conjunctivitis

Topical 0.1% Bromfenac Sodium for Intraoperative Miosis Prevention and Prostaglandin E2 Inhibition in Femtosecond Laser-Assisted Cataract Surgery

Comparison of Latanoprost and Brimonidine in the Treatment of Open Angle Glaucoma

Sodium hyaluronate and pranoprofen improve visual function and reduce inflammation in patients with dry eye

A multicenter, randomized, parallel-group, clinical trial comparing the safety and efficacy of loteprednol etabonate 0.5%/tobramycin 0.3% with dexamethasone 0.1%/tobramycin 0.3% in the treatment of Chinese patients with blepharokeratoconjunctivitis.

Preservative-Free Topical Anesthetic Unit-Dose Eye Drops for the Management of Postoperative Pain Following Photorefractive Keratectomy

Efficacy and Safety of Travoprost Versus Timolol to Treat Early-Onset Ocular Hypertension Secondary to Vitrectomy: A Randomized Trial

Bromfenac Sodium 0.1%, Fluorometholone 0.1% and Dexamethasone 0.1% for Control of Ocular Inflammation and Prevention of Cystoid Macular Edema after Phacoemulsification